150 related articles for article (PubMed ID: 37376963)
21. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
[TBL] [Abstract][Full Text] [Related]
22. Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA; Swan AV; van Doorn PA
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD002063. PubMed ID: 25238327
[TBL] [Abstract][Full Text] [Related]
23. The Effect of Biologics in the Treatment of Multisystem Inflammatory Syndrome in Children (Mis-C): A Single-Center Propensity-Score-Matched Study.
Basaran O; Batu ED; Kaya Akca U; Atalay E; Kasap Cuceoglu M; Sener S; Balık Z; Karabulut E; Kesici S; Karagoz T; Ozsurekci Y; Bilginer Y; Cengiz AB; Ozen S
Children (Basel); 2023 Jun; 10(6):. PubMed ID: 37371276
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study.
Dizon BLP; Redmond C; Gotschlich EC; Sule S; Ronis T; Vazzana KM; Sherman MA; Connor R; Bosk A; Dham N; Harahsheh AS; Wells E; DeBiasi R; Srinivasalu H
Pediatr Rheumatol Online J; 2023 Jul; 21(1):76. PubMed ID: 37525200
[TBL] [Abstract][Full Text] [Related]
25. The role of systemic immunomodulatory treatment and prognostic factors on chronic ocular complications in Stevens-Johnson syndrome.
Kim DH; Yoon KC; Seo KY; Lee HS; Yoon SC; Sotozono C; Ueta M; Kim MK
Ophthalmology; 2015 Feb; 122(2):254-64. PubMed ID: 25262319
[TBL] [Abstract][Full Text] [Related]
26. [Efficacy and safety of glucocorticoids in addition to intravenous immunoglobulin in the initial treatment of Kawasaki disease: a meta-analysis of randomized trials].
Hu JW; Zhou ZS; Yang L; Zheng CN; Wang KD
Zhonghua Yi Xue Za Zhi; 2011 May; 91(18):1259-64. PubMed ID: 21756798
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcomes of initial dexamethasone treatment combined with a single high dose of intravenous immunoglobulin for primary treatment of Kawasaki disease.
Lim YJ; Jung JW
Yonsei Med J; 2014 Sep; 55(5):1260-6. PubMed ID: 25048483
[TBL] [Abstract][Full Text] [Related]
28. Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA; Swan AV; van Doorn PA
Cochrane Database Syst Rev; 2012 Jul; (7):CD002063. PubMed ID: 22786476
[TBL] [Abstract][Full Text] [Related]
29. Intravenous immunoglobulin for presumed viral myocarditis in children and adults.
Robinson J; Hartling L; Vandermeer B; Crumley E; Klassen TP
Cochrane Database Syst Rev; 2005 Jan; (1):CD004370. PubMed ID: 15674945
[TBL] [Abstract][Full Text] [Related]
30. Mycoplasma-associated Stevens-Johnson syndrome in children: retrospective review of patients managed with or without intravenous immunoglobulin, systemic corticosteroids, or a combination of therapies.
Ahluwalia J; Wan J; Lee DH; Treat J; Yan AC
Pediatr Dermatol; 2014; 31(6):664-9. PubMed ID: 25424206
[TBL] [Abstract][Full Text] [Related]
31. Postdischarge Glucocorticoid Use and Clinical Outcomes of Multisystem Inflammatory Syndrome in Children.
Son MBF; Berbert L; Young C; Dallas J; Newhams M; Chen S; Ardoin SP; Basiaga ML; Canny SP; Crandall H; Dhakal S; Dhanrajani A; Sagcal-Gironella ACP; Hobbs CV; Huie L; James K; Jones M; Kim S; Lionetti G; Mannion ML; Muscal E; Prahalad S; Schulert GS; Tejtel KS; Villacis-Nunez DS; Wu EY; Zambrano LD; Campbell AP; Patel MM; Randolph AG;
JAMA Netw Open; 2022 Nov; 5(11):e2241622. PubMed ID: 36367723
[TBL] [Abstract][Full Text] [Related]
32. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
Jone PN; Anderson MS; Mulvahill MJ; Heizer H; Glodé MP; Dominguez SR
Pediatr Infect Dis J; 2018 Oct; 37(10):976-980. PubMed ID: 29461447
[TBL] [Abstract][Full Text] [Related]
33. Clinical Profile and Short-Term Outcome of Children With SARS-CoV-2 Related Multisystem Inflammatory Syndrome (MIS-C) Treated With Pulse Methylprednisolone.
Sugunan S; Bindusha S; Geetha S; Niyas HR; Kumar AS
Indian Pediatr; 2021 Aug; 58(8):718-722. PubMed ID: 33876782
[TBL] [Abstract][Full Text] [Related]
34. Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis.
Chen S; Dong Y; Kiuchi MG; Wang J; Li R; Ling Z; Zhou T; Wang Z; Martinek M; Pürerfellner H; Liu S; Krucoff MW
JAMA Pediatr; 2016 Dec; 170(12):1156-1163. PubMed ID: 27749951
[TBL] [Abstract][Full Text] [Related]
35. The Role of Glucocorticoids in the Treatment of Multisystem Inflammatory Syndrome (MIS-C)-Data from POLISH MIS-C Registry.
Gowin E; Toczyłowski K; Sulik A; Wysocki J; Januszkiewicz-Lewandowska D
Children (Basel); 2022 Feb; 9(2):. PubMed ID: 35204900
[TBL] [Abstract][Full Text] [Related]
36. Fever pattern and C-reactive protein predict response to rescue therapy in Kawasaki disease.
Nakagama Y; Inuzuka R; Hayashi T; Shindo T; Hirata Y; Shimizu N; Inatomi J; Yokoyama Y; Namai Y; Oda Y; Takamizawa M; Harita Y; Oka A
Pediatr Int; 2016 Mar; 58(3):180-184. PubMed ID: 26222760
[TBL] [Abstract][Full Text] [Related]
37. Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial.
van Koningsveld R; Schmitz PI; Meché FG; Visser LH; Meulstee J; van Doorn PA;
Lancet; 2004 Jan; 363(9404):192-6. PubMed ID: 14738791
[TBL] [Abstract][Full Text] [Related]
38. Intravenous immunoglobulin for the treatment of Kawasaki disease.
Broderick C; Kobayashi S; Suto M; Ito S; Kobayashi T
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014884. PubMed ID: 36695415
[TBL] [Abstract][Full Text] [Related]
39. Treatments and Severe Outcomes for Patients Diagnosed With MIS-C at Four Children's Hospitals in the United States, March 16, 2020-March 10, 2021.
Shah AB; Abrams JY; Godfred-Cato S; Kunkel A; Hammett TA; Perez MA; Hsiao HM; Baida N; Rostad CA; Ballan W; Ede K; Laham FR; Kao CM; Oster ME; Belay ED
Pediatr Infect Dis J; 2023 Nov; 42(11):990-998. PubMed ID: 37862698
[TBL] [Abstract][Full Text] [Related]
40. Bradycardia Associated with Prednisolone in Children with Severe Kawasaki Disease.
Nagakura A; Morikawa Y; Sakakibara H; Miura M
J Pediatr; 2017 Jun; 185():106-111.e1. PubMed ID: 28343657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
